By Sheri Kasprzak
New York, Aug. 5 - Biosignal Ltd. said it has arranged, through placement agent Taylor Collison, a A$1 million private placement.
The company plans to sell 5,882,350 shares at A$0.17 each.
The shares come with options for 2,941,175 shares, exercisable at A$0.20 each through Dec. 31, 2006.
Proceeds from the offering will be used for contact lens trials and for working capital.
Based in Eveleigh, New South Wales, Biosignal produces synthetic compounds used on inanimate and animate surfaces.
| Issuer: | Biosignal Ltd.
|
| Issue: | Stock
|
| Amount: | A$1 million
|
| Shares: | 5,882,350
|
| Price: | A$0.17
|
| Options: | 2,941,175
|
| Option expiration: | Dec. 31, 2006
|
| Option price: | A$0.20
|
| Pricing date: | Aug. 5
|
| Stock price: | A$0.20 at close Aug. 5
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
